🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double-blind, randomized, study at a single clinical site investi...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2002-10
Trial ID
NCT01367561
Treatments Being Tested
It is hypothesized that using methylnaltrexone in addition to pain killer n...
Status
Withdrawn
Location
Hahnemann University Hospital
Start Date
2010-10
Trial ID
NCT01360372
Treatments Being Tested
This double-blind, randomized, two-cohort, placebo-controlled, parallel gro...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2006-10
Trial ID
NCT01366365
Treatments Being Tested
This study evaluates the safety of multiple doses of IV MNTX in normal heal...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2002-04
Trial ID
NCT01367587
Treatments Being Tested
This is an open-label, radiotracer study, to be conducted in healthy, norma...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2005-06
Trial ID
NCT01367483
Treatments Being Tested
Ticagrelor is associated with more prompt and potent antiplatelet effects c...
Status
Completed
Location
University of Florida
Start Date
2015-08
Trial ID
NCT02403830
Treatments Being Tested
This open-label study assesses the single-dose pharmacokinetics of intraven...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2007-01
Trial ID
NCT01366378
Treatments Being Tested
Primary Objective: In subjects who have undergone segmental colectomy, the ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00387309
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2009-11
Trial ID
NCT01015222
Treatments Being Tested
A double-blind, randomized, parallel-group study designed to evaluate the s...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-07
Trial ID
NCT01367548
Treatments Being Tested